Microbix Biosystems Stock Today

MBX Stock  CAD 0.41  0.03  7.89%   

Performance

Weak

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
Microbix Biosystems is selling at 0.41 as of the 20th of March 2025; that is 7.89% up since the beginning of the trading day. The stock's open price was 0.38. Microbix Biosystems has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat weak performance during the last 90 days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
Category
Healthcare
Classification
Health Care
Microbix Biosystems Inc., a life science company, manufactures viral and bacterial antigens and reagents for the diagnostics industry worldwide. Microbix Biosystems Inc. was founded in 1988 and is based in Mississauga, Canada. MICROBIX J is traded on Toronto Stock Exchange in Canada.. The company has 141.64 M outstanding shares of which 5.25 K shares are now shorted by private and institutional investors with about 0.04 days to cover all short positions. More on Microbix Biosystems

Moving together with Microbix Stock

  0.68BN BrookfieldPairCorr

Moving against Microbix Stock

  0.53PPL Pembina Pipeline CorpPairCorr
  0.33DOL DollaramaPairCorr

Microbix Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Microbix Biosystems' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Microbix Biosystems or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEOCameron Groome
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors)
Microbix Biosystems' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Microbix Biosystems' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Debt Levels
Microbix Biosystems can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Microbix Biosystems' financial leverage. It provides some insight into what part of Microbix Biosystems' total assets is financed by creditors.
Liquidity
Microbix Biosystems cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. Microbix Biosystems has accumulated 111.12 K in total debt with debt to equity ratio (D/E) of 0.53, which is about average as compared to similar companies. Microbix Biosystems has a current ratio of 1.61, which is within standard range for the sector. Debt can assist Microbix Biosystems until it has trouble settling it off, either with new capital or with free cash flow. So, Microbix Biosystems' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Microbix Biosystems sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Microbix to invest in growth at high rates of return. When we think about Microbix Biosystems' use of debt, we should always consider it together with cash and equity.

Capital Expenditures

1.12 Million
Microbix Biosystems (MBX) is traded on Toronto Exchange in Canada and employs 14 people. Microbix Biosystems is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 57.36 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Microbix Biosystems's market, we take the total number of its shares issued and multiply it by Microbix Biosystems's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Microbix Biosystems operates under Biotechnology sector and is part of Health Care industry. The entity has 141.64 M outstanding shares of which 5.25 K shares are now shorted by private and institutional investors with about 0.04 days to cover all short positions. Microbix Biosystems has accumulated about 402.12 K in cash with 4.35 M of positive cash flow from operations.
Check Microbix Biosystems Probability Of Bankruptcy
Ownership Allocation
Microbix Biosystems maintains a total of 141.64 Million outstanding shares. Microbix Biosystems secures 14.19 % of its outstanding shares held by insiders and 0.4 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Microbix Ownership Details

Microbix Biosystems Risk Profiles

Although Microbix Biosystems' alpha and beta are two of the key measurements used to evaluate Microbix Biosystems' performance over the market, the standard measures of volatility play an important role as well.

Microbix Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Microbix Biosystems without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Earnings Calls Now

   

Earnings Calls

Check upcoming earnings announcements updated hourly across public exchanges
All  Next Launch Module

Microbix Biosystems Corporate Executives

Elected by the shareholders, the Microbix Biosystems' board of directors comprises two types of representatives: Microbix Biosystems inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Microbix. The board's role is to monitor Microbix Biosystems' management team and ensure that shareholders' interests are well served. Microbix Biosystems' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Microbix Biosystems' outside directors are responsible for providing unbiased perspectives on the board's policies.
James CurrieChief Financial OfficerProfile
Kenneth HughesChief Operating OfficerProfile

Other Information on Investing in Microbix Stock

Microbix Biosystems financial ratios help investors to determine whether Microbix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Microbix with respect to the benefits of owning Microbix Biosystems security.